CheckPoints is a brand that specializes in preventing infection outbreaks and ensuring clarity in hours through fast and accurate molecular detection. They recognize the rising global issue of antimicrobial resistance (AMR) in Gram-negative bacteria and Salmonella infections in the food and animal protein production chain. To combat these problems, CheckPoints has developed innovative molecular assays that utilize the specific characteristics of DNA.

These assays can detect beta-lactam resistance in the form of carbapenemases, ESBLs, and AmpCs within Enterobacteriaceae. The use of this molecular technology allows for much faster results, providing accurate and genotypic information within just 2. 5 hours.

Additionally, CheckPoints offers a range of rapid molecular assays that aid commercial organizations and hospitals in identifying and serotyping Salmonella infection within 8 hours. With their expertise, CheckPoints actively contributes to the fight against serious health issues such as antimicrobial resistance and Salmonella infections